This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Valerie Rognon-Ravaux: Innovator in Pharmaceutical Technology
Introduction
Valerie Rognon-Ravaux is a notable inventor based in Coubron, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work has led to advancements that enhance the efficacy and delivery of medications.
Latest Patents
Valerie holds a patent for "Spherical agglomerates of telithromycin, their preparation process and their use in the preparation of pharmaceutical forms." This invention relates to spherical telithromycin clusters and outlines a method for their production. The process involves preparing a telithromycin crystal suspension, where the crystals are coated with a telithromycin insoluble phase that gradually crystallizes. These spherical telithromycin clusters are utilized in the preparation of micro-capsules, which can improve drug delivery systems.
Career Highlights
Valerie Rognon-Ravaux has dedicated her career to advancing pharmaceutical technologies. She works at Aventis Pharma S.A., where she collaborates with other experts in the field to develop innovative solutions for drug formulation and delivery. Her work has been instrumental in enhancing the effectiveness of pharmaceutical products.
Collaborations
Valerie has collaborated with Jean-Yves Godard, contributing to the development of her patented technologies. Their partnership exemplifies the importance of teamwork in the field of pharmaceutical innovation.
Conclusion
Valerie Rognon-Ravaux is a pioneering inventor whose work in pharmaceutical technology has led to significant advancements in drug formulation. Her contributions continue to impact the industry positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
